Optimizing Body Mass Index (BMI) With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
Latest Information Update: 16 May 2025
At a glance
- Drugs TCMCB 07 (Primary)
- Indications Cachexia
- Focus Adverse reactions; Therapeutic Use
- Acronyms Paradox
- Sponsors Endevica Bio
Most Recent Events
- 17 Apr 2025 According to the Endevica Bio Media Release, The first patient has been dosed in the study. And, The trial, is being conducted in partnership with WuXi Clinical.
- 17 Apr 2025 Status changed from not yet recruiting to recruiting.
- 26 Dec 2024 New trial record